Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis Dupixent significantly…
PHILADELPHIA, March 26, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…
REDWOOD CITY, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on…
Leuven, BELGIUM, Boston, MA, US - March 25, 2022 – 09.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) (the…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class…
SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Provides Stockholders Additional Time to Consider $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global InvestorsSOUTH SAN FRANCISCO, Calif.,…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery…
Dr. Mark Kaufmann Advanced Dermatology and Cosmetic Surgery Chief Medical Officer Dr. Mark Kaufmann Assumes Presidency of the American Academy…
2021 Universal Registration Document filed Charenton-le-Pont, France, (March 25, 2022 – 6:30 pm) – EssilorLuxottica announces the availability of its…